At a Glance
Why Get Tested?
To help distinguish between Crohn disease (CD) and ulcerative colitis (UC), the two most common types of inflammatory bowel disease (IBD); as an adjunct to other IBD testing
When to Get Tested?
When you have symptoms such as persistent or intermittent diarrhea and abdominal pain that your healthcare practitioner suspects may be due to an IBD; when your healthcare practitioner wants to distinguish between CD and UC
A blood sample drawn from a vein in your arm
Test Preparation Needed?
The Test Sample
What is being tested?
Anti-Saccharomyces cerevisiae antibodies (ASCA) are immune proteins that are frequently present in people who have inflammatory bowel disease (IBD). This test detects ASCA in the blood.
S. cerevisiae are common yeast found in various foods. The correlation between the presence of antibodies to S. cerevisiae and their involvement in the inflammatory bowel disease process is not understood at this time.
IBD is a group of chronic disorders, thought to be an autoimmune process, characterized by swollen and damaged tissues in the lining of the intestinal tract. The symptoms and severity of IBD vary from person to person and may fluctuate over time. Many of those affected experience flare-ups followed by periods of lessened symptoms or even remission.
Testing for ASCA can be useful in helping to distinguish between the two most common types of IBD, Crohn disease (CD) and ulcerative colitis (UC). CD can affect any part of the intestinal tract, from mouth to anus, but is primarily found in the small intestine and/or in the colon, while UC occurs in the colon.
The diagnosis of CD or UC is usually made on the basis of endoscopic testing and the examination of biopsy samples from the intestines. Because both CD and UC can be found in the colon, it can sometimes be difficult to distinguish between the two. When this occurs, ASCA testing may be helpful as ASCA is much more frequently found in people with CD than in those with UC.
Sometimes several antibodies, including ASCA, perinuclear anti-neutrophil cytoplasmic antibody (pANCA), anti-CBir1 (anti-flagellin antibody), and anti-Omp C (anti-outer membrane protein antibody), may be ordered together as a panel and the overall findings evaluated to either help distinguish between CD and UC or to try to help determine a prognosis for a person's CD. The presence of multiple antibodies may indicate the likelihood of a more aggressive disease, but negative results do not rule out aggressive disease.
How is the sample collected for testing?
A blood sample is obtained by inserting a needle into a vein in the arm.
NOTE: If undergoing medical tests makes you or someone you care for anxious, embarrassed, or even difficult to manage, you might consider reading one or more of the following articles: Coping with Test Pain, Discomfort, and Anxiety, Tips on Blood Testing, Tips to Help Children through Their Medical Tests, and Tips to Help the Elderly through Their Medical Tests.
Another article, Follow That Sample, provides a glimpse at the collection and processing of a blood sample and throat culture.
Is any test preparation needed to ensure the quality of the sample?
No test preparation is needed.
Ask a Laboratory Scientist
Form temporarily unavailable
Due to a dramatic increase in the number of questions submitted to the volunteer laboratory scientists who respond to our users, we have had to limit the number of questions that can be submitted each day. Unfortunately, we have reached that limit today and are unable to accept your inquiry now. We understand that your questions are vital to your health and peace of mind, and recommend instead that you speak with your doctor or another healthcare professional. We apologize for this inconvenience.
This was not an easy step for us to take, as the volunteers on the response team are dedicated to the work they do and are often inspired by the help they can provide. We are actively seeking to expand our capability so that we can again accept and answer all user questions. We will accept and respond to the same limited number of questions tomorrow, but expect to resume the service, 24/7, as soon as possible.
NOTE: This article is based on research that utilizes the sources cited here as well as the collective experience of the Lab Tests Online Editorial Review Board. This article is periodically reviewed by the Editorial Board and may be updated as a result of the review. Any new sources cited will be added to the list and distinguished from the original sources used.
Ananthakrishnan, A. (2013). Personalizing Therapy for Inflammatory Bowel Diseases. Medscape Multispecialty from Expert Rev Gastroenterol Hepatol. 2013;7(6):549-558. [On-line information]. Available online at http://www.medscape.com/viewarticle/810751 through http://www.medscape.com. Accessed March 2014.
Ghazi, L. (Updated 2014 January 13). Crohn Disease. Medscape Reference [On-line information]. Available online at http://emedicine.medscape.com/article/172940-overview through http://emedicine.medscape.com. Accessed March 2014.
Rowe, W. and Lichtenstein, G. (Updated 2013 November 25). Inflammatory Bowel Disease. Medscape Reference [On-line information]. Available online at http://emedicine.medscape.com/article/179037-overview through http://emedicine.medscape.com. Accessed March 2014.
Grossman, A. and Mamula, P. (Updated 2013 October 14). Pediatric Crohn Disease. Medscape Reference [On-line information]. Available online at http://emedicine.medscape.com/article/928288-overview through http://emedicine.medscape.com. Accessed March 2014.
Basson, M. (Updated 2013 May 27). Ulcerative Colitis. Medscape Reference [On-line information]. Available online at http://emedicine.medscape.com/article/183084-overview through http://emedicine.medscape.com. Accessed March 2014.
(Updated 2013 December 17). Anti-Saccharomyces Cerevisiae Antibodies, IgA and IgG. The University of Iowa Department of Pathology LABORATORY SERVICES HANDBOOK [On-line information]. Available online at http://www.healthcare.uiowa.edu/path_handbook/handbook/test1155.html through http://www.healthcare.uiowa.edu. Accessed March 2014.
Minerva, P. (Updated 2012 March 29). Enteropathic Arthropathies. Medscape Reference [On-line information]. Available online at http://emedicine.medscape.com/article/334746-overview through http://emedicine.medscape.com. Accessed March 2014.
Walfish, A. and Sachar, D. (Revised 2012 December). Crohn Disease. Merck Manual for Healthcare Professionals [On-line information]. Available online through http://www.merckmanuals.com. Accessed March 2014.
(Updated 2014 February). Inflammatory Bowel Disease – IBD. ARUP Consult [On-line information]. Available online at http://www.arupconsult.com/Topics/IBD.html?client_ID=LTD#tabs=0 through http://www.arupconsult.com. Accessed March 2014.
Ryan, J. D. et. al. (2013). Predicting Complicated Crohn's Disease and Surgery. Medscape Multispecialty from Aliment Pharmacol Ther. 2013;38(3):274-283. [On-line information]. Available online at http://www.medscape.com/viewarticle/807728 through http://www.medscape.com. Accessed March 2014.
(© 1995–2014). Saccharomyces cerevisiae Antibody, IgG, Serum. Mayo Clinic Mayo Medical Laboratories [On-line information]. Available online at http://www.mayomedicallaboratories.com/test-catalog/Overview/83023 through http://www.mayomedicallaboratories.com. Accessed March 2014.
(2011 December). Crohn's Disease. National Digestive Diseases Information Clearinghouse (NDDIC) [On-line information]. Available online at http://digestive.niddk.nih.gov/ddiseases/pubs/crohns/ through http://digestive.niddk.nih.gov. Accessed March 2014.
(Updated 2011 April 30). Diagnosing and Managing IBD. Crohn's & Colitis Foundation of America [On-line information]. Available online at http://www.ccfa.org/resources/diagnosing-and-managing-ibd.html through http://www.ccfa.org. Accessed March 2014.
Yau, Y. et. al. (2013). Proteomics and Metabolomics in Inflammatory Bowel Disease. Medscape Multispecialty from J Gastroenterol Hepatol. 2013;28(7):1076-1086. [On-line information]. Available online at http://www.medscape.com/viewarticle/807024 through http://www.medscape.com. Accessed March 2014.
Kuna, A. (2013 February). Serological markers of inflammatory bowel disease. Biochem Med (Zagreb). Feb 2013; 23(1): 28–42. [On-line information]. Available online at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900099/ through http://www.ncbi.nlm.nih.gov. Accessed March 2014.
Wu, A. (© 2006). Tietz Clinical Guide to Laboratory Tests, 4th Edition: Saunders Elsevier, St. Louis, MO. Pp 966-967.